Analysis of relative expression level of VEGF (vascular endothelial growth factor), HIF-1 (hypoxia inducible factor 1) and CTGF (connective tissue growth factor) genes in chronic glomerulonephritis (CGN) patients

Kidney and Blood Pressure Research

Volumn 38, Issue 1, 2014, Pages 83-91

  Donderski, Rafał ^a   Szczepanek, Joanna ^a,b   Domagalski, Krzysztof ^a,b   Tretyn, Andrzej ^a   Korenkiewicz, Jadwiga ^b   Marszałek, Andrzej ^b   Szymański, Andrzej ^b   Wolski, Zbigniew ^b   Odrowa̧z Sypniewska, Grazyna ^a   Manitius, Jacek ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Department of Pediatrics Hematology and Oncology ^*  (Poland)

Author keywords

Chronic glomerulonephritis; Chronic kidney disease (CKD); Relative gene expression level; Tubulointerstitial compartment damage

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; ARTICLE; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HISTOPATHOLOGY; HOUSEKEEPING GENE; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY PARENCHYMA; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MEAN ARTERIAL PRESSURE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; REAL TIME POLYMERASE CHAIN REACTION; URINARY EXCRETION; CONTROLLED STUDY; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRANULOMATOSIS; HUMAN TISSUE; HYPERTENSIVE NEPHROPATHY; MEMBRANOUS GLOMERULONEPHRITIS; AGED; BIOSYNTHESIS; CHRONIC DISEASE; GENETICS; GLOMERULONEPHRITIS; KIDNEY; METABOLISM; MIDDLE AGED; PATHOLOGY; RENOVASCULAR HYPERTENSION;

AGED; CHRONIC DISEASE; CONNECTIVE TISSUE GROWTH FACTOR; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; GLOMERULONEPHRITIS; HUMANS; HYPERTENSION, RENAL; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY; MALE; MIDDLE AGED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84895672287     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000355754     Document Type: Article

References (25)

1. Kretzler M, Cohen C, Doran P, Henger A, Madden S, Grne EF, Nelson PJ, Schlndorff D, Grne HJ: Repuncturing the renal biopsy: Strategies for molecular diagnosis in nephrology. J Am Soc Nephrol 2002;13:1961-1972.
2. Eikmans M, Baelde H, Hagen EC, Paul LC, Eilers PH, De Heer E, Bruijn JA: Renal mRNA levels as prognostic tools in kidney diseases. J Am Soc Nephrol 2003;14:899-907.
3. von Schnakenburg C, Strehlau J, Ehrich JH, Melk A: Quantitative gene expression of TGF?1,IL10, TNF? and Fas Ligand in renal cortex and medulla. Nephrol Dial Transplant 2002;17:573-579.
4. Schrijvers B, Flyvbjerg A, de Vries A : The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 2004;65:2003-2017.
5. Blom I, van Dijk A, Wieten L, Duran K, Ito Y, Kleij L, deNichilo M, Rabelink TJ, Weening JJ, Aten J, Goldschmeding R: In vitro evidence for differential involvement of CTGF, TGF? and PDGF-BB in mesangial response to injury. Nephrol Dial Transplant 2001;16:1139-1148.
6. Kroening S, Solomovitch S, Sachs M, Wullich B, Goppelt-Struebe M: Regulation of connective tissue growth factor (CTGF) by hepatocyte growth factor in human tubular epithelial cells. Nephrol Dial Transplant 2009;24:755-762.
7. Nangaku M, Inagi R, Miyata T, Fujita T: Hypoxia and Hypoxia-Inducible Factor in Renal Disease. Nephron Exp Nephrol 2008;110:1-7.
8. Ju W, Eichinger F, Bitzer M, Oh J, McWeeney S, Berthier CC, Shedden K, Cohen CD, Henger A, Krick S, Kopp JB, Stoeckert CJ Jr, Dikman S, Schrppel B, Thomas DB, Schlondorff D, Kretzler M, Bttinger EP: Renal Gene and Protein Expression Signatures for Prediction of Kidney Disease Progression. Am J Pathol 2009;175:1349.
9. Boner G, Cox A, Kelly DJ, Tobar A, Bernheim J, Langham RG, Cooper ME, Gilbert RE: Does vascular endothelial growth factor (VEGF) play a role in the pathogenesis of minimal change disease? Nephrol Dial Transplant 2003;18:2293-2299.
10. Shulman K, Rosen S, Tognazzi K, Manseau EJ, Brown LF: Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. J Am Soc Nephrol 1996;7:661-666.
11. Boerries M, Grahammer F, Eiselein S, Buck M, Meyer C, Goedel M, Bechtel W, Zschiedrich S, Pfeifer D, Lalo D, Arrondel C, Gonalves S, Krger M, Harvey SJ, Busch H, Dengjel J, Huber TB: Molecular fingerprinting of the podocyte reveals novel gene and protein regulatory networks. Kidney International 2013;10:487-490
12. Mayer G: Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease. Nephrol Dial Transplant 2011;26:1132-1137.
13. Thilo F, Liu Y, Loddenkemper C, Schuelein R, Schmidt A, Yan Z, Zhu Z, Zakrzewicz A, Gollasch M, Tepel M: VEGF regulates TRPC6 channels in podocytes. Nephrol Dial Transplant 2012;27:921-929.
14. Kang D-H, Hughes J, Mazzali M, Schreiner G, Johnson R: Impaired angiogenesis in the remnant kidney model: II Vascular Endothelial Growth Factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 2001;12:1448-1457.
15. Lindenmeyer M, Kretzler M, Boucherot A, Berra S, Yasuda Y, Henger A, Eichinger F, Gaiser S, Schmid H, Rastaldi M, Schrier R, Schlondorff D, Cohen C: Interstitial Vascular Rarefaction and Reduced VEGF-A Expression in Human Diabetic Nephropathy. J Am Soc Nephrol 2007;18:1765-1776.
16. Kang D-H, Joly A, Oh S-W, Hugo Ch, Kerjaschi D, Gordon K, Mazzali M, Jefferson J, Hughes J, Madsen K, Schreiner G, Johnson R: Impaired angiogenesis in remnant kidney model: I. Potential role of Vascular Endothelial Growth Factor and Thrombospondin-1. J Am Soc Nephrol 2001;12:1434-1447.
17. Kobayashi T, Okada H, Inoue T, Kanno Y, Suzuki H: Tubular expression of connective tissue growth factor correlates with interstitial fibrosis in type 2 diabetic nephropathy. Nephrol Dial Transplant 2006;21:548-549.
18. Ito Y, Aten J, Bende R, Oemar B, Rabelink T: Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998;53:853-861.
19. Schodel J , Bohr D, Klanke B, Schley G, Schltzer-Schrehardt U, Warnecke C, Kurtz A, Amann K, Eckardt KU, Willam C: Factor inhibiting HIF limits the expression of hypoxia-inducible genes in podocytes and distal tubular cells. Kidney Int 2010;78:857-867.
20. Nangaku M, Eckardt K-U: Hypoxia and the HIF system in kidney disease. J Mol Med 2007;85:1325-1330.
21. Freeburg PB, Robert B, St John PL, Abrahamson DR: Podocyte Expression of Hypoxia-Inducible Factor (HIF)-1 and HIF-2 during Glomerular Development. J Am Soc Nephrol 2003;14:927-938.
22. Rudnicki M, Perco P, Enrich J, Eder S, Heininger D, Bernthaler A, Wiesinger M, Sarkzi R, Noppert SJ, Schramek H, Mayer B, Oberbauer R, Mayer G: Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease. Lab Invest 2009;89:337-346.
23. Song YR, You SJ, Lee YM, Chin HJ, Chae DW, Oh YK, Joo KW, Han JS, Na KY: Activation of hypoxia -inducible factor attenuates renal injury in rat remnant kidney. Nephrol Dial Transplant 2010;25:77-85.
24. Cohen D, Grone H, Grone E, Nelson P, Schlndorff D, Kretzler M: Laser microdissection and gene expression analysis on formaldehyde-fixed archival tissue. Kidney Int 2002;61:125-132.
25. Cohen D, Frach K, Schlondorff D, Kretzler M: Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throuhput multicenter application. Kidney Int 2002;61:133-140.